Reparixin

reparixin · Dompé Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Reparixin, covering 2019-10-09 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia [Phase 3]

See pricing